Hims & Hers stock is on the upswing after the company secured a weight-loss drug partnership. Hims & Hers is acquiring its ...

AMY Childs was seen preparing to jet away for TOWIE filming after backlash over her weight and her postponed wedding. The ...

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, ...

Amy Childs reveals she ‘can’t stop being sick’ and is in ‘the worst pain’ days after weight loss backlash The Towie OG previously lost two stone following the birth of her twins, Millie and Billy.

Hims & Hers Health sees some volatility with revenue growth, 38% subscriber increase, and promising telehealth market demand.

MitoRx Therapeutics Limited (MitoRx), today announces results for its novel small molecule Myo4 targeting obesity. In the diet induced obesity (DIO) mouse model, Myo4 reduced weight while preserving ...

Growing At-Home Men's Health Program in North America-PeterMD's Telemedicine Clinic Offers Transparent, Doctor-Supervised TRT ...

Kim Kardashian is stunning in her romantic blue lingerie as she promotes SKIMS, but haters are calling her "fat." ...

The team at Omada Health took a victory lap Friday after the company's successful Nasdaq debut, according to company ...

Women’s healthcare company Wisp has launched a diagnostics arm to offer low-cost testing at home for sexual and reproductive ...